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ㅋ
Constipation in children is a common health problem affecting 0.7% to 29.6% children across the world. Exact etiology for 
developing symptoms is not clear in children and the majority is considered to have functional constipation. Alteration of rec-
tal and pelvic floor function through the brain-gut axis seems to play a crucial role in the etiology. The diagnosis is often a 
symptom-based clinical process. Recently developed Rome III diagnostic criteria looks promising, both in clinical and research 
fields. Laboratory investigations such as barium enema, colonoscopy, anorectal manometry and colonic transit studies are rarely 
indicated except in those who do not respond to standard management. Treatment of childhood constipation involves several 
facets including education and demystification, toilet training, rational use of laxatives for disimpaction and maintenance and 
regular follow-up. Surgical options should be considered only when medical therapy fails in long standing constipation. Since 
most of the management strategies of childhood constipation are not evidence-based, high-quality randomized controlled trials 
are required to assess the efficacy of currently available or newly emerging therapeutic options. Contrary to the common be-
lief that children outgrow constipation as they grow up, a sizable percentage continue to have symptoms beyond puberty.
(J Neurogastroenterol Motil 2011;17:35-47)
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Introduction
Constipation is one of the commonest digestive complaints in 
children, which has recently grown to quite a proportion in public 
health problem. Like many other functional disorders, its etiolo-
gy, pathophysiology and prognosis are ill-understood. This re-
sults in strongly-held, believes-driven and self-introduced man-
agement strategies, which are blended with the culture of the 
country, sometimes even harmful to children. However, body of 
the scientific knowledge has grown both in depth and width dur-
ing the last decade. This article focuses on current views on defi-
nition, epidemiology, clinical features, evaluation and manage-
ment strategies of constipation in children.
Definitions
Constipation has long been considered a symptom, rather than 
a disease.
1 It is often perceived as infrequent motions or passage 
of hard stools. Some defined constipation as less than 3 bowel mo-
tions per week
2 or as difficulty in passing stools.
3 Approximately 
0.5% of school children have defecation frequency less than 3 per Shaman Rajindrajith and Niranga Manjuri Devanarayana
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week and 0.3% have fecal incontinence.
4 Furthermore, 20% of 
children also have at least 1 clinical feature of constipation.
5 There-
fore, it is important to use diagnostic criteria based on multiple 
symptoms to define constipation. 
In 1999, Rome II criteria were developed to diagnose defeca-
tion disorders.
6 Functional constipation was identified in infants 
and preschool children and functional fecal retention in older chi-
ldren. Subsequently, Rome II criteria were found to be too re-
strictive in diagnosing defecation disorders because they did not 
include cardinal features of constipation (fecal incontinence) as 
diagnostic criteria and demanded persistence of symptoms for at 
least 3 months.
7,8 Furthermore, division of functional constipa-
tion and functional fecal retention has no implications in clinical 
practice. However, the Rome process established a pathway to 
formulate universally acceptable diagnostic criteria for childhood 
defecation disorders through international collaboration. 
The pediatric Rome III criteria were released in 2006 (Ta-
ble 1). Functional constipation was recognized as a separate clin-
ical entity by combining features of functional fecal retention and 
functional constipation. Furthermore, duration of symptoms was 
reduced to 8 weeks.
9 A recent community-based study compar-
ing Rome II and Rome III criteria shows a 2.5-fold increase in 
prevalence of functional constipation.
10 The more inclusive na-
ture of the Rome III criteria seems to have stemmed from includ-
ing cardinal clinical features of constipation in the diagnostic cri-
teria and necessity of shorter duration of symptoms.
Epidemiology
Global burden of childhood constipation is often underap-
preciated. This was mainly due to lack of data in this age group. 
In epidemiological studies, the definitions vary from accepted 
Rome criteria to proxy reports by parents. A recent systematic re-
view in pediatric age group reported constipation in 0.7% to 
29.6%.
11 Apart from differences in definitions, the variation in 
duration of symptoms needed to diagnose constipation, age dis-
tribution of the children studied and the method of data collec-
tion may also have an influence on the data. Studies that have 
used standard definitions like Rome II criteria have also showed 
wide ranges of prevalence.
12,13 Therefore, apart from varying def-
initions, several other factors seem to be responsible for the  hete-
rogeneity of epidemiological data, including environmental, so-
cio-cultural and genetic factors. 
Until recently, it was believed that constipation is a disease of 
the developed world, but studies from Asia have reported equally 
high prevalence of constipation. A survey in Sri Lanka using 
Rome III criteria reported constipation in 10.6% of 10-16 years 
old.
14 Similarly, prevalence of constipation in Japan was 18.5%.
15
Gender specific prevalence of constipation also varies be-
tween studies. Some studies have reported no difference in pre-
valence of constipation between girls and boys,
3,12,16,17 while oth-
ers found significantly higher prevalence in girls.
13 Another stu-
dy found a clear negative correlation between prevalence of con-
stipation and age.
18
The available data indicate that constipation is on the rise. A 
recent analysis of longitudinal data in the USA beginning from 
1979 showed nearly 4-fold increase in rates of constipation dur-
ing the last decade. There was a surge in both outpatient clinic 
visits and hospitalizations due to constipation between 1992 and 
2004, with more than a doubling of rates in diagnosing consti-
pation from outpatient clinics and nearly 4-fold increase in rates 
of hospital discharge under the diagnosis of constipation. Fur-
thermore, children under 15 years had the highest number of 
clinic visits for constipation.
19 In addition, 5.4 million prescrip-
tions were filled for constipation in the USA in 2004. All these 
facts prove that constipation is a growing health problem among 
children worldwide.
Risk Factors
Several risk factors have been identified in association with 
pediatric constipation. The main risk factors for constipation are 
listed in Table 2. 
Low consumption of dietary fiber has long been considered 
as one of the leading risk factors. Undigested fibers in the colon 
are thought to increase the colonic transit and increase stool out-
put. Lee et al
20 found that kindergarten children with constipa-
tion took significantly low median dietary fiber than non con-
stipated children. Furthermore, fruits and total plant food intake 
were significantly lower in the constipated group.
20 Two other 
studies among older children also noted that children with con-
stipation consume significantly less amount of dietary fiber than 
controls.
21,22 Available studies from Asia also show that fiber 
consumption in Asian countries such as Hong Kong
20,23 and Mal-
dives
24 is lower than the recommended values.
Few studies have demonstrated its relationship with psycho-
logical factors. Inan et al
25 has shown that physical or psycho-
logical trauma and personal health problems were associated with 
constipation in school-aged children. Furthermore, they have fo-
und that abnormal oral habits (which were considered as an in-Constipation in Children
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Table 1. Pediatric Rome III Criteria for Constipation
Rome III criteria for neonates and toddlers
Must include 1 mo of at least two of the following in infants up to 4 yr 
of age:
    1. Two or fewer defecations per week
    2. At least 1 episode per week of incontinence after the acquisition of 
toileting skills
    3. History of excessive stool retention
    4. History of painful or hard bowel movements
    5. Presence of a large fecal mass in the rectum
    6. History of large-diameter stools that may obstruct the toilet
Accompanying symptoms may include irritability, decreased appetite 
and/or early satiety.
The accompanying symptoms disappear immediately following pass-
age of a large stool.
Rome III criteria for children and adolescents
Must include two or more of the following in a child with a develop-
mental age of at least 4 yr
a with insufficient criteria for diagnosis of 
irritable bowel syndrome:
    1. Two or fewer defecations in the toilet per week
    2. At least 1 episode of fecal incontinence per week
    3. History of retentive posturing or excessive volitional stool reten-
tion
    4. History of painful or hard bowel movements
    5. Presence of a large fecal mass in the rectum
    6. History of large diameter stools that may obstruct the toilet
aCriteria fulfilled at least once per week for at least 2 mo before diagnosis.
Table 2. Causes and Risk Factors of Constipation in Children
Intestinal causes Hirschsprung disease
Anorectal malformations
Neuronal intestinal dysplasia
Metabolic/endocrine causes Hypothyroidism
Diabetics mellitus
Hypercalcemia
Hypokalaemia
Vitamin D intoxication
Drugs Opioids
Anticholinergics
Antidepressants
Other causes Anorexia nervosa
Sexual abuse
Scleroderma
Cystic fibrosis
Risk factors Low fiber diet
Psychological stress
Cow’s milk protein allergy
Familial predisposition
Prematurity
Living in urban areas
direct measure of psychological stress) also showed a significant 
association with constipation.
25 A study from Sri Lanka involving 
school children of 10-16 years old noted that school-related stress-
ful events such as separation from best friend, bullying at school, 
failure of exam and family-related events such as severe illness of 
family member, parents’ job loss and frequent punishment by pa-
rents were predisposing them to develop constipation.
26 Further-
more, children living in a war-affected area had high prevalence 
of constipation compared to non war-affected areas.
26 Psycholo-
gical factors including emotional stress are likely to modulate co-
lonic and rectal functions, through the brain gut axis, leading to 
constipation.
Cow’s milk protein allergy is considered as a risk factor for 
constipation. Several studies have reported reduction of consti-
pation by elimination of cow’s milk from diet.
27,28 However fur-
ther studies are needed to confirm this association and to intro-
duce cow’s milk-free diet to infants and children with constipa-
tion. Other demonstrated risk factors are extreme low birth wei-
ght,
29 positive family history
18,21 and living in urban areas.
18,30 
High consumption of junk foods with low fiber content and sed-
entary life style might have contributed to higher prevalence of 
constipation reported in children living in urban areas. 
Pathophysiology
The pathophysiology of constipation in children is multi-fac-
torial and is associated with interactions of many risk factors. 
Many organic diseases cause constipation (Table 2). However, 
the majority of constipation patients secondary to organic con-
ditions usually have other clinical features suggestive of the rele-
vant underlying organic disease. Organic diseases presenting as 
isolated constipation are rather uncommon. 
Over 90% of children with this condition have functional 
constipation.
31 Borowitz et al
32 reported painful defecation as the 
commonest factor for constipation. If there is pain during defeca-
tion, children usually withhold stools. During the withholding, 
rectal mucosa absorbs water from the fecal mass, which becomes 
harder and larger as the time passes and ultimately defecation be-
comes difficult. Therefore, when the desire to pass stools comes, 
children adopt retentive posture, hide from parents till the urge 
pass off. Passage of this fecal mass is painful and sometimes re-
sults in anal fissures which further aggravate pain and precipitate 
stool withholding. This sets up a vicious cycle of stool retention. 
Accumulation of stools in rectum causes gradual dilatation lead-
ing to megarectum resulting in loss of rectal sensation and urge Shaman Rajindrajith and Niranga Manjuri Devanarayana
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for defecation. It had been shown that children with megarectum 
have high sensory threshold for rectal sensation.
33,34
Other intestinal pathologies leading to chronic constipation 
surprisingly have not received much attention. Several studies 
have demonstrated slow colonic transit in 25%-69% children with 
constipation.
35-37 Furthermore, those with slow transit constipa-
tion had more severe symptoms including night time soiling.
35 
Laparoscopic biopsies of the colon have shown deficiency of neu-
rotransmitters such as substance P in some children.
38,39 Further-
more it was shown that number of antegrade pressure waves in 
the colon was significantly decreased in children with slow transit 
constipation.
40
Clinical Features
The commonest symptoms of constipation are reduced stool 
frequency and passage of hard stools. The other symptoms in-
clude fecal soiling, passage of large volume stools, painful defeca-
tion and characteristic “retentive posturing.” Straining at defeca-
tion, abdominal pain, anorexia, vomiting and bleeding per rectum 
are other associated features, although they are excluded from the 
diagnostic criteria.
16,18 Similarly constipation was the commonest 
cause of acute abdominal pain presenting to emergency depart-
ment or primary care clinics.
41 The physical examination shows 
palpable fecal masses in the abdomen and fecal impaction in the 
rectum.
Evaluation
A detail history and thorough physical examination are the 
cornerstones in assessing a child with chronic constipation. These 
2 steps would reveal the possible etiology and associated compli-
cations in the majority. Investigations are only needed in those 
who show clinical features of organic diseases and children do not 
respond to initial medical management.
Clinical History
History of meconium passage
Neonates pass meconium within first 48 hours. Delayed pas-
sage of meconium raises the possibility of short segment Hir-
schsprung disease and anorectal malformations. 
Time of onset
A majority develop constipation around 2-4 years of age.
42 
Significant intestinal pathologies such as anorectal malformations 
and neuronal intestinal dysplasia are common in children pre-
senting with constipation very early in life. In some patients, the 
onset of symptoms is related to major stressful life events such as 
birth of a sibling or parental job loss.
Bowel habits and defecation behaviors
The majority of children with constipation have infrequent 
passage of stools. Hard and large caliber stools that can clog the 
toilet may lead to passage of blood with stools. Adaptation of 
withholding posture should be specifically questioned because 
sometimes parents interpret this as a genuine attempt to pass 
stools. Children stand on tip toes and often hold on to furniture 
till the desire for defecation is passed. Sweating and facial redness 
are also noted in this period. Leaking stools into the underwear 
without realizing indicates severe constipation.
Associated symptoms
Although non-specific, the presence of abdominal pain, nau-
sea, and vomiting are associated with constipation. Most parents 
would complain the child has loss of appetite and fail to gain 
weight. History of urinary incontinence is also a feature.
43 Endo-
crine diseases which may cause constipation, such as diabetes 
mellitus would have features such as polyuria, polydipsia and 
weight loss. Furthermore, children with hypothyroidism may pre-
sent with lethargy, poor school performances and weight gain.
Drugs
It is vital to take a history on current medications when as-
sessing for constipation as certain drugs lead to constipation as 
adverse effects (Table 2).
Psychology
A detail history of psychological state is another important 
part in the assessment. It may reveal features of anorexia nervosa, 
depression and anxiety.
Risk factors
All other possible risk factors for the development of con-
stipation are discussed above. General medical history, social de-
tails and the developmental history are also integral components 
in the assessment. 
Physical Examination
Physical growth
Measurement of height and weight and comparison with the 
age appropriate centile charts gives idea about the physical growth. 
Hypothyroidism and other organic disorders may present as short 
stature or failure to thrive.
General examination
Young children with constipation often cling to their parents 
and look frightened during the consultation. Smell of the faeces Constipation in Children
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due to incontinence and general demeanor of the child are also 
important to note. Children with anorectal malformation and hy-
percalcaemia may sometimes show associated features. Young 
girls with anorexa nervosa often would show features of weight 
loss. Presence of scars, lipomas and haemangiomas on the lower 
spine would suggest the possibility of spinal dysraphism and un-
derlying neurological abnormalities.
Abdominal examination
The main aim of the abdominal examination is to assess the 
presence of palpable fecal mass. Usually it is found in the left iliac 
fossa or supra pubic region. 
Perianal inspection and digital examination of the rec-
tum
Inspection of the perianal region shows position of the anus, 
fissures, tags and inflammation. Children who had experienced 
chronic sexual abuse would show characteristic features. Repair-
ed anorectal malformations would show surgical scars around the 
anus. Digital rectal examination assesses the anal tone and detects 
the presence of fecal mass. It is noted that the frequency of digital 
examination of rectum is unacceptably low in children with con-
stipation.
44
Neurological assessment
This will reveal neurological abnormalities in the lower spinal 
cord which may present as constipation. 
Investigations
Laboratory investigations are rarely indicated in childhood 
constipation except in those with evidence of organic diseases 
from history and examination and in those who do not respond 
to adequate medical management. Otherwise, investigations are 
unlikely to reveal any additional information for the management.
Plain abdominal X-ray
Plain abdominal radiograph is performed to identify the de-
gree of fecal loading in the colon and rectum.
45-47 It is considered 
to be useful in children who are not willing to undergo a rectal ex-
amination due to pain and fear.
5 However a systematic review 
shows that interpretation of the radiological findings is difficult, 
inconsistent and there is a poor correlation between clinical and 
radiological diagnosis.
48 The scoring systems for fecal loading are 
reported to have wide inter-observer and intra-observer varia-
bility, poor diagnostic accuracy, poor reproducibility and depend 
on the experience of the scorer.
49,50 Therefore, plain abdominal 
radiograph has a very limited value in clinical assessment of con-
stipation.
Colonic transit studies
The transit time of the colon is studied using radio-opaque 
markers
51-53 and radionuclear scintigraphy.
54 The calculated total 
and segmental transit times allow to differentiate constipation due 
to delayed segmental and pan-colonic transit from constipation 
with normal transit.
51,55,56 
Several previous studies have reported delayed colonic transit 
times (segmental or total) in children with constipation.
36-38,49,57 
de Lorijin and co-workers
57 reported delayed transit on rectosig-
moid (48%) followed by descending and ascending colon (21%- 
22%). Another study showed slow transit constipation in 60% of 
the children with constipation and of them, 13% had pelvic floor 
dysfunction.
38 Children with slow transit constipation have low-
er defecation frequency and higher prevalence of day and night 
time soiling, painful defecation and palpable rectal or abdominal 
masses.
35,37,58 Therefore, colonic transit studies are beneficial in 
children with chronic treatment-resistant constipation to deter-
mine colonic transit abnormalities. 
Anorectal manometry
Anorectal manometry is a collection of several tests that mea-
sure pressure changes in the rectum and the anal canal. It is often 
combined with surface electrode electromyography of the ex-
ternal anal sphincter and puborectalis muscle.
36 They provide de-
tails on rectal sensation, state of recto-anal inhibitory reflex, tone 
of anal sphincter and defecation dynamics. 
Some studies have shown an increased threshold for rectal 
sensation in constipated children especially those with megarec-
tum.
33,34 However probably the most important benefit of ano-
rectal manometry in children with constipation is to exclude Hir-
schsprung disease. Generally, presence of recto-anal inhibitory 
reflex excludes Hirschsprung disease. However several studies 
have noted variable sensitivity, specificity, positive and negative 
predictive values in the diagnosis of Hirschsprung disease.
59-64 
Furthermore, false positive results may occur due to immaturity 
of ganglion cells (in premature babies) and artefacts.
61 Therefore 
in cases with strong clinical suspicion of Hirschsprung disease, it 
is imperative to perform a suction biopsy to confirm or exclude 
the diagnosis.
Defecation dynamics are tested using anorectal manometry 
with integrated electromyogram of the external anal sphincter and 
puborectalis muscle. It is defined abnormal if there is increased 
manometric and myoelectrical activities in the sphincter complex 
during bearing down.
34 Pelvic floor dyssynergia was noted among 
constipated children in several studies.
65-67 Previous studies have 
shown that children with constipation have abnormally high rest-Shaman Rajindrajith and Niranga Manjuri Devanarayana
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ing anal tone.
65-67 In contrast, another study failed to show a dif-
ference in anal tone between constipated children and controls.
34
Colonic manometry
Colonic manometry measures the intracolonic pressure using 
a multichannel manometry probe. It is useful in patients with in-
tractable constipation. Children with functional constipation show 
normal colonic motor activity (presence of high amplitude prop-
agating contractions and gastro-colonic response to meal). Child-
ren with rare colonic muscle disorders demonstrate absent or 
weak colonic contractions. The gastro-colonic response is absent 
in colonic neuropathy.
68
By analyzing 375 colonic manometries, Villarreal et al
69 fo-
und colonic neuropathy in 130 and colonic myopathy in 15 and 
signified the diagnostic validity of colonic manometry in intract-
able constipation. Another study noted 30% of 173 children to 
have colonic neuromuscular diseases.
70 Colonic manometry via 
appendicostomy has shown abnormal high amplitude contrac-
tions, increased retrograde propagating sequences and lack of in-
crease in amplitude of propagating sequences normally induced 
by meals and waking.
40 
Therefore, it is an important investigation in children with 
chronic treatment-resistant constipation, who do not respond to 
maximum doses of combined laxative therapy. Significant mano-
metric abnormalities in such clinical situations make the clinician 
to think about other management options such as antegrade co-
lonic enemas or surgical interventions. 
Other investigations 
Fecoflowmetry evaluates pressure changes in the rectum and 
anal canal during infusion of saline and also evacuation rates of 
saline from the rectum using uroflowmeter. Previous study has 
shown abnormalities in pressure curves and fecoflowmetry curves 
in children with chronic constipation.
71 Pelvic ultrasonograpy has 
been used to measure the diameter of the rectum in children with 
chronic constipation. These studies have shown larger rectal di-
ameter in children with constipation compared to controls.
72,73 
Anal endosonography has also revealed abnormalities in the 
sphincter complex in children with chronic constipation.
74 How-
ever these investigations need further validation before using in 
routine evaluation of affected children.
Management
Management of constipation encompasses several facets. 
However, only few randomized controlled trials are available to 
assess therapeutic options currently being used in treatment. In 
addition, little is known of their optimum therapeutic dosages 
and long-term side effects. Therefore, management of childhood 
constipation is mainly based on individual experience. 
In the management of chronic constipation, a trustworthy re-
lationship between the patient, parents and clinician is of para-
mount importance. The key steps in management include educa-
tion and demystification, treatment of fecal impaction, mainten-
ance therapy and close follow-up. Steps in management of child-
hood constipation are illustrated in the Figure.
Education 
The general public has various concepts on constipation 
which may interfere with proper clinical management. Therefore 
educating the parents and patients about pathophysiology and 
precipitating factors will help to alleviate anxiety, minimize accu-
sations and increase their involvement in management. Approxi-
mately 15% of children with constipation improve with nonac-
cusatory education, demystification and toilet training.
75 It is also 
worth mentioning to parents that the progress of treatment is of-
ten irregular and is marked by periods of improvement alternat-
ing with deterioration. Therefore, the duration of maintenance 
therapy ranges from 6 to 24 months.
21,76 
Behavioral Therapy
Behavioral therapies for constipation are designed to regu-
larize toilet routines, discourage stool withholding and improve 
understanding of defecation dynamics. Several protocolized beha-
vioral programs has been used as therapeutic interventions.
77,78 
The stepwise approach described by van Dijk et al
78 included se-
veral steps. Psycho-education is used as the first step to change 
behavior of parents and child towards constipation. Reduction of 
anxiety towards defecation using education and models is helpful 
to promote successful defecation. In the next step, child is taught 
of straining techniques such as relaxation of legs and feet, to take 
a deep breath and hold it and how to push down while holding 
one’s breath. Finally the behavior is reinforced by motivation and 
reward system and develops toilet routine without avoidance.
78 A 
randomized control trial which compared conventional treatment 
alone and conventional treatment with added behavioral therapy 
failed to demonstrate significant difference in improvement of 
defecation frequency and fecal soiling.
79 In contrast to this, a web 
based behavioral therapy plus laxatives with conventional treatme-
nt showed reduced fecal soiling, increased defecation in the toilet, 
and increased unprompted trips to the toilet in study group.
80
Nevertheless, use of these non-invasive steps would enhance Constipation in Children
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Figure. Algorithm of management of 
childhood constipation. PEG, polyethyle-
ne glycol; ACE, antegrade conlonic ene-
ma.
passing stools, improve strained family relationships and build a 
rapport between clinician and family. Therefore, behavioral ther-
apy involving steps described above should be used in children 
presenting with chronic constipation.
Biofeedback Therapy
Biofeedback uses electrical or mechanical devices to increase 
the awareness of physiological functions of anal sphincter by pro-
viding the patient with visual, verbal and or auditory information 
and enhances self-control on body functions.
81 During biofeed-
back, patients are provided with visual graphs of their rectal pres-
sure and electromyography of external anal sphincter and also 
taught to relax external anal sphincter with the rise of rectal 
pressure. This therapy is likely to be beneficial for the subgroup 
of patients with pelvic floor dyssynergia and enable them to relax 
their pelvic floor and external anal sphincter in achieving normal 
defecation. In agreement with this, several previous studies have 
shown the efficacy of biofeedback therapy in correcting abnormal 
defecation dynamics.
33,82,83 However, it failed to demonstrate an 
additional therapeutic value in clinical improvement of chronic 
constipation in children.
65 Therefore, at present, biofeedback the-
rapy seems to be beneficial for only a small subgroup of children 
with chronic constipation who have pelvic floor dyssynergia.
Dietary Measures
It is a wide spread practice to instruct patients with con-Shaman Rajindrajith and Niranga Manjuri Devanarayana
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stipation to increase fluid and fiber intake. According to 2 stud-
ies, increased fluid intake only resulted in increased urine output 
and had no effect on stool output or consistency.
84,85 In agreement 
with this, another study showed that increased water intake by 
50% did not improve stool frequency or consistency.
86
Low fiber intake has been recognized as a risk factor for 
constipation. Adequate intake of dietary fiber (age + 5 in grams) 
reduces risk of constipation, but further increase in fiber has no 
proven therapeutic value. Previous clinical trials failed to show 
significant improvement of bowel habits after fiber treatment 
compared to placebo and traditional treatments such as lactu-
lose.
87,88 In one study, a subgroup analysis showed that children 
with prolonged basal colonic transit times significantly increases 
number of bowel motions after administration of high fiber diet.
89 
Disimpaction
Evacuation of feces accumulated in the rectum is the key 
therapeutic step in successful management of constipation. Seve-
ral studies have assessed the value of polyethylene glycol (PEG) 
in fecal disimpaction. One study proved that PEG 3350 without 
electrolytes has cleared fecal impaction in 75% of children with 
constipation and children using higher doses had more clearance 
than those using lower doses.
41 In agreement with this, Pashank-
er et al
90 showed that, after 8 weeks of treatment with PEG with-
out electrolytes, children had less fecal soiling, painful defecation, 
fecal impaction and rectal dilatation.
Another study showed that PEG 3350 plus electrolytes is 
more effective in disimpaction compared to suppositories or rec-
tal enemas.
91 In addition, health costs and hospital admissions 
were reduced when using PEG compared to enemas and sup-
positories.
91 Furthermore, PEG 3350 plus electrolytes was effec-
tive in clearing fecal retention in chronic treatment resistant con-
stipation. In another study, 90% of children with treatment re-
sistant constipation were successfully treated with PEG.
92
Administration of enemas to relieve rectal fecal loading has 
long been practiced in management of childhood constipation. It 
is important that clinicians use the rectal route, only when oral 
drugs have failed. Insertion of rectal enema may be extremely dis-
turbing to the child who might already have anal fissures. There-
fore, it needs to be given under sedation to minimize pain and 
psychological effects. Otherwise it may disturb the good relation-
ship and understanding between clinician and child, which is es-
sential in the long term management. 
Maintenance Therapy
After achieving disimpaction it is vital to start daily oral lax-
atives to keep the stool soft thereby to prevent re-impaction. The 
duration of the maintenance phase needs to be individualized and 
may vary from months to years. Parents and children need to be 
counselled regarding the importance of this stage and should 
keep a regular bowel chart. Parents need to be advised on differ-
ent alternatives to use if the child does not pass stools on a regular 
basis. A close follow-up is crucial during the initial period of ma-
intenance to avoid recurrence. The main pharmacological agents 
used for maintenance are osmotic and stimulant laxatives.
31,93 
Table 3 gives recommended dosage of laxatives commonly used 
during this phase. 
Osmotic laxatives
Lactulose. It is an unabsorbable, osmotically active carbo-
hydrate which drags water into the gut, keeps the stools soft 
and facilitates passage of stools without pain. Two randomized 
controlled trials comparing lactitol and lactulose have found that 
both are equally effective in increasing stool frequency and nor-
malizing stool consistency.
31,94,95 When lactulose was compared 
with senna in a crossover trial, both drugs were found to be effec-
tive in improving defecation frequency.
96
Polyethylene glycol. PEG is a non absorbable compound 
and is not digested by colonic bacteria. Its mechanism of action is 
increasing osmotic load in the large intestine which results in ex-
pansion of stool volume.
97 In a prospective observational study, 
Pashankar et al
98 failed to find any side effects following PEG 
therapy. PEG has not altered the serum electrolyte, osmolality 
and albumin levels of plasma and liver and renal functions.
98 In a 
double blind randomized controlled trial, Candy et al
92 noted that 
PEG with electrolytes was more effective compared to lactulose 
in increasing defecation frequency in children with intractable 
constipation. Furthermore, children on PEG plus electrolytes 
had less fecal impaction and did not need rescue medication.
92 In 
a randomized, crossover study comparing PEG with lactulose, 
parents felt that PEG was more effective compared to lactulose, 
even though there was no difference in frequency of bowel mo-
tions, stool form or easy passage of stools between 2 groups.
99 
Two other double blind randomized controlled trials failed to 
demonstrate a significant difference in stool frequency between 
PEG and lactulose.
100,101Two studies comparing PEG without 
electrolytes with milk of magnesia found no difference between 2 
drugs with regard to outcome.
102,103 Therefore current evidence 
shows no advantage of one osmotic laxative over the others dur-Constipation in Children
43 Vol. 17, No. 1 January, 2011 (35-47)
Table 3. Drugs Commonly Used in the Management of Childhood Constipation
Drug class Laxative Dosage Side effects
  Osmotic laxatives
Magnesium hydroxide 3-12 yr, 5-10 mL/day
13-18 yr, 25-50 mL
Colics
Lactulose 1-5 yr, 5 mL twice a day
6-10 yr, 10 mL twice daily
11-18 yr, 15 mL twice daily
(1-3 mL/kg twice daily)
Flatulence, abdominal discomfort, cramps
PEG 3350-4000
  maintenance
0.26-0.84 g/day Loose stools, bad taste, abdominal distension,
  abdominal pain, nausea
PEG 3350 disimpaction 1-1.5 g/kg/day (3 to 4 days) Loose stools, bad taste, abdominal distension,
  abdominal pain, nausea
  Stimulating laxatives
Bisacodyl oral 4-10 yr, 5 mg at night
11-18 yr, 5-10 mg at night
Abdominal cramps, abdominal pain
Bisacodyl rectal 2-10 yr, 5 mg in the morning
11-18 yr, 10 mg in morning
Abdominal cramps, anal irritation
Senna tablets
  (7.5 mg per tablet)
6-12 yr, 1-2 tablets at night
13-18 yr, 2-4 tablets at night
Abdominal cramps, melanosis coli, electrolyte
  imbalance
Senna granules
  (15 mg in 5 mL)
6-12 yr, 2.5-5 mL at night
13-18 yr, 5-10 mL at night
Abdominal cramps, electrolyte imbalance
Sodium picosulphate 2-4 yr, 0.25 mg/kg at night
5-10 yr, 2.5-5 mg at night
11-18 yr, 5-10 mg at night
Abdominal cramps
Docusate sodium 6 mo-2 yr, 12.5 mg, 3 times a day
3-12 yr, 12.5-25 mg, 3 times a day
13-18 yr, up to 500 mg daily in divided
  doses
Abdominal cramps
  Stool softeners
Liquid praffin 3-12 yr, 0.5-1 mL/kg (max 30 mL) twice
  daily
13-18 yr, 10-30 mL once daily
Anal irritation in prolonged use
Granulomatous reaction caused by absorption
PEG, polyethylene glycol.
ing the maintenance phase of management. 
Stimulant laxatives
Good quality clinical trials are lacking on effectiveness of sti-
mulant laxative as maintenance therapy of childhood constipation 
and therefore it is difficult to draw evidence based conclusions. 
An open label randomized controlled trial comparing senna and 
lactulose showed no difference in bowel frequency. However, 
number of patients passing normal stools each day was signi-
ficantly higher in patients receiving lactulose.
94 Sondheimer and 
Gervaise
104 noted that children using fecal softeners (mineral oil) 
had more daily motions and less fecal soiling than senna. Other 
stimulant laxatives such as bisacodyl, docusate sodium and so-
dium picosulphate have not been evaluated in randomized con-
trolled trials.
New Therapeutic Options
Tegaserod
It is a serotonin receptor agonist which stimulates the peri-
staltic reflex, enhances intestinal secretions and decreases visceral 
sensitivity.
105 It also act as a prokinetic agent in the upper and 
lower gastrointestinal tract.
106 There are several trials of this drug 
in adults with constipation predominant irritable bowel syndrome 
and constipation. However the efficacy of this drug has not been 
evaluated in children.
Probiotics
A randomized control trial on the effectiveness of Lactoba-
cillus GG as an adjunct to lactulose for children with constipation 
failed to show additional therapeutic benefit.
107 Another study Shaman Rajindrajith and Niranga Manjuri Devanarayana
44 Journal of Neurogastroenterology and Motility 
that compared the efficacy of probiotics containing Lactobacillus 
casei ramnosus with magnesium oxide to a placebo, failed to show 
a significant difference in final outcome between probiotics and 
MgO.
108 More robust therapeutic trials are needed before rec-
ommending probiotics for routine management of constipation.
Surgery
Surgical options need to be considered only when medical 
therapy fails in long standing constipation. Children with loaded 
rectum who do not respond to enemas may need manual eva-
cuation.
109 Sigmoid resection and removal of dilated megasig-
moid is a successful surgical intervention in some patients with 
severe constipation.
110 Antegrade colonic enema via appendico-
caecostomy is another surgical therapeutic option in severe func-
tional constipation.
111,112 Possible complications of this interven-
tion include stenosis of the cutaneous opening, leakage around 
the cecostomy tube and displacement of the tube.
113,114
Prognosis
Van Ginkel et al
76 noted that 30% of children with consti-
pation continued to have symptoms beyond puberty with several 
complications associated with it. A recent systematic review on 
prognosis of childhood constipation noted that the majority of 
them recover within 6-12 months of therapy and the recovery rate 
had no relationship with the age of onset, positive family history, 
defecation frequency and presence of fecal incontinence.
115
Conclusion
Chronic constipation is a common pediatric problem affect-
ing children worldwide. Exact etiology is unclear in the majority 
and is thought to be functional in origin. Constipation is a clinical 
diagnosis and investigations are rarely warranted, unless clues are 
found in the history or physical examination or poor response to 
therapy. Key steps in the management include education, rectal 
disimpaction, maintenance and follow-up. Approximately 30% of 
affected children will continue to have symptoms beyond puberty 
contrary to the common belief that children outgrow constipa-
tion.
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